FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Why Are FDA-483 Observations the Same?

Former FDAer Steve Lynn asks what the drug industry and regulators can do working together to break the cycle of more than 20 years of the same CGMP i...

latest-news-card-1
Federal Register

FDA Seeks Nonvoting Device Panel Members

Federal Register notice: FDA selects interested industry organizations to participate in selecting nonvoting industry representatives to serve on cert...

latest-news-card-1
Federal Register

FDA Terminating Winnes Debarment

Federal Register notice: FDA grants a special termination of the debarment of David Winne due to his cooperation with federal officials.

latest-news-card-1
Biologics

Panel Backs Sickle Cell Gene Therapy Safety

FDAs Cellular, Tissue, and Gene Therapies Advisory Committee supports Vertex Pharmaceuticals and CRISPR Therapeutics safety assessments on their sickl...

latest-news-card-1
Human Drugs

FDA Expects Increasing Cannabis Research

An FDA post reviews 50 years of agency involvement in cannabis research and predicts the increase seen in recent years will continue.

latest-news-card-1
Human Drugs

Unlicensed Wholesaler Sentenced to Prison

A Florida federal judge sentences Marina Sievert to two years in federal prison for mail fraud and introducing into interstate commerce a foreign unap...

latest-news-card-1
Human Drugs

Tonix Shuts Down Depression Drug Development

Tonix Pharmaceuticals discontinues the development program for major depressive disorder candidate TNX-601 ER based on disappointing efficacy results ...

latest-news-card-1
Human Drugs

New FDA Off-Label Guide Has Challenges: Lawyers

Sidley Austin attorneys pull five takeaways, including challenges, from a recent FDA draft guidance on off-label communications between companies and ...

latest-news-card-1
Human Drugs

FDA Sends 8-item 483 to NATCO Pharma

FDA issues NATCO Pharma an eight-item Form FDA-483 after concluding an inspection of the firms Telangana, India, manufacturing facility 10/18.

latest-news-card-1
Human Drugs

API CGMP Deviations at Ali Pharmaceutical

FDA warns Omaha, NE-based Ali Pharmaceutical Manufacturing about significant CGMP deviations for active pharmaceutical ingredients.